Shares of Microbot Medical Inc. rocketed 67.3% toward a nine-month high on heavy volume in premarket trading Monday, after the pre-clinical medical device company announced an agreement with Stryker ...
Hosted on MSN
FDA clears Microbot’s LIBERTY endovascular robot
The US Food and Drug Administration (FDA) has cleared Microbot’s LIBERTY, a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot completed the ACCESS-BVI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback